Medical release archive
Here you can find the archive of all Medical releases prior to 2021
Filter by date:
Showing 69 medical releases before 2021
-
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis
-
Brilinta reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had an acute ischaemic stroke or transient ischaemic attack
-
Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status
-
Brilinta reduced subsequent disabling stroke or death in patients who had an acute ischaemic stroke or transient ischaemic attack in Phase III THALES trial sub-analysis
-
Anifrolumab reduces disease flares in patients with systemic lupus erythematosus while allowing oral corticosteroid tapering
-
Fasenra significantly reduced exacerbation rate for severe eosinophilic asthma patients in Phase IIIb ANDHI trial
-
AstraZeneca licenses preclinical porcupine inhibitor, RXC006, for idiopathic pulmonary fibrosis
-
Anifrolumab showed early and sustained treatment benefit for patients with systemic lupus erythematosus in the TULIP clinical trial programme
-
Lokelma label update approved in EU for patients with hyperkalaemia on stable haemodialysis
-
Lokelma US label updated to include dosing guidance for the treatment of hyperkalaemia in patients with end-stage renal disease on haemodialysis
Latest articles and press releases
All of our latest press releases and articles are available to explore